Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Sep 02 2020
Published Sep 2 2020
3 min read

Press Release Sep 02 2020

Cadila Healthcare Limited has informed the Exchange regarding a press release dated September 02, 2020, titled "Zydus Cadila receives final approval from the USFDA for Cisatracurium Besylate Injection".

View Attachment